Lutropin alfa

促黄体激素α

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLutropin alfa
Drug Alias Name促黄体素αlutropine alfa促黄体生成素lutropina alfaLutropin alpha +[14] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonistsOvarian follicle stimulants
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsHypogonadismInfertility, FemaleInfertility
Global Approved IndicationsInfertility, Female
Approved Indications in ChinaInfertility, Female
Original Approved Country/TerritoryEU
Original Approved Date2000/11/29
Country/TerritoryCanadaItalySpain +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesMerck Europe BvInstituto Valenciano De Infertilidad, Ivi AlicanteAzienda Ospedaliero-Universitaria Di Modena +[4] 
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsHypogonadismInfertility, Female
Inactive IndicationsInfertility

Other Information

ATC CodeG03GA07
Related LinksWikipediaDrugBankKEGG